Q4 Results Highlights: Texmaco Rail Profit at ₹57.7 Crore; Cohance Lifesciences Profit at ₹20 Crore Dalal Street experienced a busy earnings session in the fourth quarter, with major companies reporting their financial results. Key players such as Dr Reddy’s Laboratories, Tata Power, and Torrent Power shared their performance, while others like Texmaco Rail and Cohance Lifesciences stood out with notable profit figures. The market saw mixed outcomes, with some firms reporting declines in profitability and others showing strong growth. Texmaco Rail reported a net profit of ₹57.7 crore for the quarter, up from ₹39.8 crore in the same period last year. Revenue declined slightly to ₹1,167 crore from ₹1,346.4 crore, but EBITDA increased to ₹106.4 crore from ₹97.6 crore. The company’s margin improved to 9.1% compared to 7.3% in the previous year. Cohance Lifesciences, meanwhile, recorded a net profit of ₹20 crore, a significant drop from ₹120.4 crore in the prior year. Revenue fell to ₹619.1 crore from ₹840.4 crore, with EBITDA decreasing to ₹98.7 crore from ₹229.2 crore. The company’s margin dropped to 15.9% from 27.3%. Dr Reddy’s Laboratories faced a sharp decline in profitability, with net profit plunging 86.2% year-on-year to ₹220 crore. Revenue also fell 12% to ₹7,516.2 crore, and margins contracted to 13% from 29.1%. Tata Power reported a net profit of ₹996 crore, down from ₹1,043 crore in the previous year. Revenue declined to ₹14,900 crore from ₹17,096 crore, while EBITDA dropped to ₹2,599.2 crore from ₹3,246 crore. Torrent Power also saw a significant drop in profit to ₹318.2 crore, down from ₹1,060 crore, despite flat revenue and stable margins. Several other companies reported mixed results.#tata_power #torrent_power #dr_reddys_laboratories #texmaco_rail #cohance_lifesciences
